PTSM: Pharmaceutical Technology Sourcing and Management, Jan 9, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jan 9, 2013
Global Feature
2013: The Year Ahead
By Patricia Van Arnum
As a new year begins, what may be on the horizon for 2013 for the biopharmaceutical/pharmaceutical companies and their suppliers? A look ahead into what issues are shaping the industry.
Biologics
Venture-Capital Stays Strong in Biotech Financing
By Patricia Van Arnum
Financing from initial public offerings and global mergers and acquisitions were down in 2012 and venture-capital funding stayed strong.
Outsourcing
Acquisitions Reshape the Bio/Pharm Services Industry
By Jim Miller
The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.
CSR and Sustainability Forum
GlaxoSmithKline Uses Mobile Technology to Advance Vaccinations in the Developing World
By Patricia Van Arnum
GlaxoSmithKline partners with the mobile telecommunications company Vodafone to tackle common infectious diseases in Africa.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here